ADHERENCE TO THE FIRST-LINE THERAPY WITH DISEASE MODIFYING DRUGS IN PATIENTS WITH MULTIPLE SCLEROSIS

The article is devoted to the question of multiple sclerosis patients’ adherence to therapy. Interpretation of research data on the compliance of patients, the level of their physical and emotional state, and adherence to treatment depending on disease duration, severity of neurological symptoms and used medication are presented in the article. The results showed the level of adherence to treatment to be dependent on a number of factors. Patients with high levels of anxiety and depression demonstrated lower levels of adherence. The article stresses that it is necessary to diminish anxiety and depression level in patients with clinical and subclinical levels, because they influence significantly physical condition of patients. It is concluded that an attending physician should take into consideration patients’ adherence to therapy.

multiple sclerosis, multiple sclerosis disease modifying drugs, adherence to therapy